Molecular Subtypes in Stage II-III Colon Cancer Defined by Genomic Instability: Early Recurrence-Risk Associated with a High Copy-Number Variation and Loss of RUNX3 and CDKN2A

• Marianne Berg,

  Affiliations Centre of Organelle Research (CORE), University of Stavanger, Stavanger, Norway, Department of Gastrointestinal Surgery, Stavanger University Hospital, Stavanger, Norway

  ⨯
• Oddmund Nordgaard,

  Affiliation Department of Hematology and Oncology, Stavanger University Hospital, Stavanger, Norway

  ⨯
• Hartwig Kørner,

  Affiliations Department of Gastrointestinal Surgery, Stavanger University Hospital, Stavanger, Norway, Department of Clinical Medicine, University of Bergen, Bergen, Norway

  ⨯
• Satu Oltedal,

  Affiliation Department of Hematology and Oncology, Stavanger University Hospital, Stavanger, Norway

  ⨯
• Rune Smaaland,

  Affiliation Department of Hematology and Oncology, Stavanger University Hospital, Stavanger, Norway

  ⨯
• Jon Arne Søreide,

  Affiliations Department of Gastrointestinal Surgery, Stavanger University Hospital, Stavanger, Norway, Department of Clinical Medicine, University of Bergen, Bergen, Norway

  ⨯
• Kjetil Søreide

  * E-mail: kjetil.soreide@k1.uib.no

  Affiliations Department of Gastrointestinal Surgery, Stavanger University Hospital, Stavanger, Norway, Department of Clinical Medicine, University of Bergen, Bergen, Norway

  ⨯